Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Long-Term Safety and Effects of Maralixibat for Patients with Alagille Syndrome
ItalyStudy of mRNA-4157 and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
ItalyStudy of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer
ItalyStudy on Cemiplimab and OSE2101 for Maintenance Therapy in Patients with ctDNA Positive Non-Small Cell Lung Cancer (NSCLC)
ItalyStudy on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
ItalyStudy on the Effectiveness of Lisaftoclax and Azacitidine in Adults with Newly Diagnosed Higher Risk Myelodysplastic Syndrome
ItalyLong-term Safety and Efficacy Study of Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome
ItalyStudy of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors
ItalyStudy of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation
ItalyStudy Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide
ItalyStudy of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer
ItalyStudy Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
